FDA Inspection 1021866 — Nataliya P. Shilkina
The FDA completed an inspection of Nataliya P. Shilkina on July 19, 2017 in Yaroslavl 150023. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 19, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Yaroslavl 150023 (Russia)
Additional Details
Clinical Investigator (CI)